TNFSF11 and osteoporosis: Therefore, bone resorption should be reduced and/or bone formation should be enhanced.30 Currently, most available anti‐osteoporosis therapies, such as anti‐RANKL antibodies and bisphosphonates, mainly focus on decreasing bone resorption.